Discover 3,049 paid clinical trials in Thousand Oaks, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,049
A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Beverly Hills CA, Irvine CA, Goodyear AZ, Denver CO,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07589634
Phase 2, Recruiting
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort
for
Chronic Kidney Disease
Location: Glendale CA, San Antonio TX, Saint Paul MN, Chicago IL
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT07024823
Phase 1, Recruiting
PTT-936 Alone or in Combination in Patients With Locally Advanced or Metastatic Solid Tumors
for
Locally Advanced or Metastatic Solid Tumors
Location: Beverly Hills CA, San Antonio TX, Margate FL
Sponsor: Pyrotech Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06244992
Phase 1, Phase 2, Recruiting
Zanubrutinib in Combination With Odronextamab for the Treatment of Patients With Richter's Transformation
Improving Behavioral Health for Caregivers and Children After Pediatric Injury
for
Quality of Life, PTSD, Depression Not Otherwise Specified,
Location: Los Angeles CA, Houston TX, Lexington KY, Ann Arbor MI
Sponsor: Medical University of South Carolina
Sex: All
Age: 18+
Code: NCT06856057
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
for
Non-small Cell Lung Cancer
Location: Beverly Hills CA, Bakersfield CA, Billings MT,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06345729
Phase 3, Recruiting
A Dose Escalation Study of AV-380 in Cancer Patients With Cachexia
for
Cachexia
Location: Beverly Hills CA, Lakewood CA, Newport Beach CA,
Sponsor: AVEO Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT05865535
Phase 1, Recruiting
Fimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing Disease
for
Cushing Disease
Location: Los Angeles CA
Sponsor: University of California, Los Angeles
Sex: All
Age: 18+
Code: NCT05971758
Phase 2, Recruiting
A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab
Location: Los Angeles CA, Huntington Beach CA, Austin TX,
Sponsor: Regenerative Patch Technologies, LLC
Sex: All
Age: 55 - 70+
Code: NCT06557460
Phase 2, Recruiting
Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Torrance CA, South Pasadena CA, Arcadia CA, Duarte CA,
Sponsor: City of Hope Medical Center
Sex: Female
Age: 40+
Code: NCT06954831
Phase 2, Recruiting
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
for
High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements,
Location: Los Angeles CA, Oregon City OR, Newberg OR,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06649812
Phase 2, Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
for
Non-small Cell Lung Cancer
Location: Beverly Hills CA, Los Alamitos CA, Anaheim CA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06692738
Phase 3, Recruiting
A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL
for
CTCL
Location: Duarte CA, Rochester NY, Richmond VA, New Haven CT,
Sponsor: Prescient Therapeutics, Ltd.
Sex: All
Age: 18+
Code: NCT06854653
Phase 2, Recruiting
Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metastatic NSCLC or Solid Tumors With Bone Metastases
for
Carcinoma, Non-Small-Cell Lung Cancer,
Location: Beverly Hills CA, Tyler TX, Pittsburgh PA, Norfolk VA
Sponsor: Kiromic BioPharma Inc.
Sex: All
Age: 18+
Code: NCT06069570
Phase 1, Recruiting
ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial